The bacteria that express enzymes capable of degrading 7-KC, which is the objective of Lysosens. Lysosens is to remove junk that builds up in cells as a process of aging
Fightaging covers the progrss on Lysosens.
Given that many different harmful metabolic waste products exist, the field of biomedical remediation has enormous scope for growth - and certainly for more funding, which should hopefully start to arrive in the wake of proof of concept work like this. There is no need to slow down after finding one or more enzymes that break down 7-ketocholesterol, as firstly there could still be far better enzymes out there for this job, and secondly there remain numerous other damaging waste compounds in our cells and tissues that are worthy of biomedical remediation.
If you liked this article, please give it a quick review on ycombinator or StumbleUpon. Thanks